ロード中...
Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized as progressive and irreversible fibrosis in the interstitium of lung tissues. There is still an unmet need to develop a novel therapeutic drug for IPF. We have previously demonstrated that periostin, a matricellular protein,...
保存先:
| 出版年: | Am J Respir Cell Mol Biol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Thoracic Society
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993541/ https://ncbi.nlm.nih.gov/pubmed/31505128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2019-0245OC |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|